Wound Care Offloading: Complete Strategy for DFU Healing

Wound Care Offloading: The Most Undertreated Factor in DFU Healing

Wound care offloading is the single most evidence-based intervention for plantar diabetic foot ulcers, yet it remains the most inconsistently applied. The data is clear: without adequate pressure redistribution, plantar DFUs do not heal, regardless of what dressing, skin substitute, or advanced therapy is used. The International Working Group on the Diabetic Foot (IWGDF) has placed offloading at the top of its treatment hierarchy for plantar forefoot ulcers since its founding, and the 2023 guidelines reaffirm this position with the strongest available evidence.

Despite this, fewer than 6% of plantar DFU patients in the United States receive the gold-standard offloading device — the total contact cast. This guide covers the offloading hierarchy, device selection, adherence challenges, and the Medicare Therapeutic Shoe Program.

The Offloading Hierarchy

Total Contact Cast (TCC): The Gold Standard

The TCC remains the highest-evidence offloading device for plantar forefoot DFUs. It works because patients cannot remove it. A properly applied TCC redistributes plantar pressure across the entire sole of the foot, reduces pressure at the ulcer site by 60-80%, and forces patient compliance by design.

Evidence: Randomized controlled trials consistently demonstrate healing rates of 73-100% at 12 weeks with TCC, compared to 32-58% with removable devices. The difference is almost entirely attributable to adherence — the TCC cannot be removed, so the offloading is continuous.

Application requirements:

Clinician skill — TCC application requires training and practice. An improperly applied TCC can cause pressure injuries, skin maceration, or falls
Weekly changes — the cast must be removed and reapplied at each wound care visit for wound assessment, debridement, and dressing change
Intact vascular status — ABI > 0.5 and palpable pulses or acceptable non-invasive vascular testing
No active infection requiring daily monitoring — the cast prevents daily wound inspection between visits
Stable wound with no significant drainage that would macerate skin under the cast

Why it is underused: The TCC requires 20-30 minutes to apply, specialized supplies, and clinician training. Many wound care providers have not been trained in TCC application, and clinic workflows are not designed for the additional time. Supply costs, liability concerns related to falls, and patient resistance also contribute.

Removable Cast Walkers (RCW): The Practical Alternative

Removable cast walkers (e.g., DH Offloading Walker, Aircast) are the most commonly used offloading devices for plantar DFUs. They are easier to apply than TCC, require no specialized training, and allow the patient to remove the device for sleeping, bathing, and wound inspection.

The problem: removability is both the advantage and the fatal flaw. Activity monitoring studies show that patients wear removable devices only 28-60% of the time they are weight-bearing. During the hours the device is off, the ulcer receives full mechanical loading, undoing much of the benefit.

Making RCWs irremovable: The IWGDF recommends rendering removable cast walkers irremovable by wrapping them with cohesive bandage or a single layer of fiberglass at the ankle. This converts the device into a functional equivalent of a TCC — the patient cannot easily remove it — while preserving the easier application process. Studies of rendered-irremovable RCWs show healing rates comparable to TCC.

Therapeutic Footwear

Therapeutic shoes and custom insoles are post-healing offloading devices, not acute ulcer treatment devices. They reduce recurrence after the ulcer has closed. Using therapeutic footwear as the primary offloading modality for an active plantar DFU is inadequate and does not meet the standard of care.

Exception: For patients with ulcers on the dorsum of the foot or non-plantar locations where pressure redistribution requirements are different, extra-depth therapeutic shoes with accommodative insoles may be appropriate primary interventions.

Patient Adherence Challenges

Why Patients Remove Offloading Devices

Understanding the reasons for non-adherence helps clinicians address them proactively:

Balance and fall risk — elderly patients with neuropathy already have impaired proprioception. Adding a bulky offloading device further destabilizes gait. Many patients remove the device out of genuine fear of falling.
Contralateral leg symptoms — the height differential between the offloaded foot and the opposite shoe causes hip and knee pain, particularly in patients with preexisting osteoarthritis. A contralateral shoe lift can mitigate this.
Activity limitations — patients cannot drive, shower comfortably, or perform household activities with the device on. These daily-life barriers are not trivial — they determine whether the device gets used.
Lack of understanding — many patients do not understand that the invisible mechanical load on the ulcer is the primary healing barrier. They see the wound as a surface problem requiring a dressing change, not a structural problem requiring pressure redistribution.

Strategies to Improve Adherence

Educate with specific language — "This ulcer exists because of pressure. Every step without the device reopens the wound at the cellular level. The device is doing more healing work than any dressing."
Render the RCW irremovable — this eliminates the choice and removes the burden of compliance from the patient
Provide a contralateral shoe lift — reduces hip and back pain from the height differential
Address fall risk directly — physical therapy referral, assistive device (cane, walker), and home safety assessment
Set expectations at the first visit — "You will wear this for 8-12 weeks minimum. We will change the dressing weekly through the cast/device."

For a full clinical pathway on managing diabetic foot ulcers including vascular assessment, infection staging, and the 4-week reassessment rule, see the comprehensive DFU guide.

Medicare Therapeutic Shoe Program

Overview

The Medicare Therapeutic Shoe Program (also known as the Diabetic Shoe Benefit) covers one pair of therapeutic shoes and three pairs of inserts per calendar year for qualifying patients with diabetes. This is a Part B benefit under DMEPOS, not a wound care benefit.

Qualifying Criteria

The patient must have diabetes AND at least one of the following conditions documented by the managing physician (not the shoe fitter):

Previous partial or complete foot amputation
History of previous foot ulceration
History of pre-ulcerative callus
Peripheral neuropathy with evidence of callus formation
Foot deformity
Poor circulation

How the Program Works

The managing physician (the physician managing the patient's diabetic condition, not necessarily the wound care provider) must certify the patient's need and the qualifying condition
A podiatrist or other qualified supplier prescribes and fits the shoes and inserts
The supplier bills Medicare using HCPCS codes A5500-A5513 for therapeutic shoes and A5510-A5512 for inserts

Clinical Importance for Wound Care

Therapeutic shoes are a recurrence prevention tool, not an active treatment tool. Once a plantar DFU has healed, transitioning the patient into Medicare-covered therapeutic footwear with custom insoles reduces recurrence by redistributing pressure across the foot surface. Without post-healing offloading, DFU recurrence rates approach 40% within one year and 65% within five years.

Document the referral for therapeutic shoe fitting in the wound care progress note when the ulcer is approaching closure. This demonstrates continuity of care and ensures the patient does not return to the footwear that caused the ulcer in the first place.

Offloading for Non-Plantar DFU Locations

Not all diabetic foot ulcers are plantar forefoot lesions. Ulcers on the heel, dorsum, medial/lateral foot, and toes require different offloading approaches.

Heel Ulcers

Heel pressure injuries and heel DFUs require offloading that eliminates contact between the heel and any surface during both ambulation and rest. Options include:

Heel suspension devices (Multi Podus boot, Prevalon heel offloader) for bed-bound or limited-ambulatory patients
Custom AFO with heel relief for ambulatory patients
TCC with heel cutout — technically feasible but requires advanced casting skill

Toe Ulcers

Digital ulcers often result from hammer toe deformity, hallux valgus, or interphalangeal joint friction. Offloading options include:

Toe spacers for interdigital ulcers
Protective toe caps with accommodative padding
Extra-depth shoes with high toe box to eliminate dorsal pressure
Surgical correction of the underlying deformity for recurrent ulcers

Key Takeaways

Total contact casting is the gold standard for plantar DFU offloading with healing rates of 73-100% at 12 weeks, yet fewer than 6% of eligible patients receive one.
Rendering removable cast walkers irremovable with cohesive bandage achieves healing rates comparable to TCC while being easier to apply and requiring no specialized training.
Patient adherence is the primary failure point — address fall risk, provide contralateral shoe lifts, and educate patients that pressure, not the wound surface, is the healing barrier.
Medicare covers therapeutic shoes and inserts annually for qualifying diabetic patients, and transitioning patients into these after wound closure is essential for recurrence prevention.
Non-plantar DFU locations require different offloading strategies — heel suspension for heel ulcers, toe spacers and protective caps for digital ulcers, and extra-depth shoes for dorsal lesions.